Funded Grants

PI Name Sort ascending PI Organization Title Grant Number Initiative Program Official
Zhang, Zhen

Johns Hopkins University
United States

A multidisciplinary BCC for ovarian cancer early detection: translating discoveries to clinical use with a by-design approach 5U2CCA271891-02 Christos Patriotis, Ph.D., M.Sc.
Zhang, Zhen

Johns Hopkins University
United States

A multidisciplinary BCC for ovarian cancer early detection: translating discoveries to clinical use with a by-design approach 5U2CCA271891-02 Christos Patriotis, Ph.D., M.Sc.
Zhang, Zhen

Johns Hopkins University
United States

A multidisciplinary BCC for ovarian cancer early detection: translating discoveries to clinical use with a by-design approach 5U2CCA271891-02 Christos Patriotis, Ph.D., M.Sc.
Zhang, Fan

University Of Florida
United States

NCI Diversity Supplement 3R21CA277263-02S1 Mark Steven Miller, Ph.D.
Zeng, Melody Yue

Weill Medical Coll Of Cornell Univ
United States

Dissecting the interplay between immunoglobulin G and the gut microbiome in cancer progression and metastasis 5R21CA270998-02 Young Kim, Ph.D.
Zarrinpar, Amir

University Of California, San Diego
United States

Engineering Native E. coli to Detect, Report, and Treat Colorectal Cancer 5U01CA265719-03 Guillermo Marquez, Ph.D.
Zada, Gabriel

University Of Southern California
United States

DNA Methylation and gene expression variations influence pituitary adenoma hormonal function and invasive growth 5R01CA230328-05
Yun, Jihye

University Of Tx Md Anderson Can Ctr
United States

Impact of sugary drinks on gut microbiota and development of young-onset colorectal cancer 7R21CA258134-02 Gabriela Riscuta, M.D., C.N.S.
Yuan, Ying

University Of Tx Md Anderson Can Ctr
United States

Coordinating and Data Management Center for Translational and Basic Science Research in Early Lesions 5U24CA274212-02 RFA-CA-21-055 (U24 Clinical Trial Not Allowed) Christos Patriotis, Ph.D., M.Sc.
Yu, Dihua

University Of Tx Md Anderson Can Ctr
United States

Exploring novel strategies for immunoprevention of estrogen receptor negative breast cancer 5R01CA270010-02 PA-20-185 (Parent R01 Clinical Trial Not Allowed) Marjorie Perloff, M.D.